title: Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.
authors.affiliation: Medical Director, Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center; Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; Consultant, The Head and Neck Institute, Portland, OR. Electronic address: richard.bell@providence.org.
authors.forename: R Bryan
authors.initials: RB
authors.lastname: Bell
authors.affiliation: Co-Director, Providence Oral, Head and Neck Cancer Program, Providence Cancer Center; Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.
authors.forename: Rom
authors.initials: R
authors.lastname: Leidner
authors.affiliation: Predoctoral student, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; MD/PhD Program, Oregon Health and Science University, Portland, OR.
authors.forename: Zipei
authors.initials: Z
authors.lastname: Feng
authors.affiliation: Director of Translational Radiation Research, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; Radiation Oncologist, Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR.
authors.forename: Marka R
authors.initials: MR
authors.lastname: Crittenden
authors.affiliation: Member and Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Gough
authors.affiliation: Chief, Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.
authors.forename: Bernard A
authors.initials: BA
authors.lastname: Fox
mesh_terms: D000912:Antibodies, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000628:therapy*; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D016246:Lymphocytes, Tumor-Infiltrating / Q000502:physiology; D009062:Mouth Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology / Q000528:radiation effects
chemical_list: D000912:Antibodies, Neoplasm; D019496:Cancer Vaccines